引用本文: | 王先明, 唐静. Pembrolizumab对进展期PD-L1阳性三阴性乳腺癌患者的安全性和疗效评估[J]. 循证医学, 2017, 17(3): 146-149. DOI: 10.12019/j.issn.1671-5144.2017.03.007 |
Citation: | WANG Xian-ming, TANG Jing. The Safety and Therapeutic Effect Evaluation of Pembrolizumab in Patients with Advanced PD-L1 Positive Triple Negative Breast Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(3): 146-149. DOI: 10.12019/j.issn.1671-5144.2017.03.007 |